The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies. By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
Wellstar Invests $10M to Become First Sharecare-Enabled Health System
Wellstar Health System, one of Georgia’s largest and most integrated healthcare systems, and Sharecare, the digital health company that helps people manage all their health in one place, announced a strategic partnership to collaborate on unique, market-leading innovations in personalized care delivery, population health, and consumer engagement. Through this partnership, Wellstar also will become the first “Sharecare-enabled” health system in the country, utilizing Sharecare’s solutions to
Read More
DarioHealth Acquires Musculoskeletal Solution Upright for $31M
What You Should Know: - DarioHealth, a Livongo competitor acquires musculoskeletal startup Upright for $31 million to expand their chronic condition management capabilities focused on driving behavior change rather than treating the acute problem. This move will more than double revenue and create one of the largest integrated digital health companies in the space. In addition, DarioHealth rasiess $70 million through a private placement of its common stock priced at the market pursuant to
Read More
Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A
What You Should Know: - DTx and Patient Support leaders, Amalgam Rx, Inc., announce the acquisition of Avhana Health, a privately-held clinical decision support (CDS) company. Amalgam Rx, Inc., a Wilmington,
DE-based Digital Therapeutics and Patient Support company, announces the acquisition
of Avhana Health, a privately held
clinical decision support (CDS) company, which has deep integrations with the
leading electronic health records (EHR). As part of the acquisition, Amalgam Rx
will
Read More
Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population
What You Should Know: - Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. - Vida’s diabetes management program
achieves lasting results for participants. Because chronic conditions like diabetes,
obesity, and hypertension often occur simultaneously, Vida’s unique program was
built from the ground up to treat multiple conditions at the same time. - The new partnership, which will
Read More
Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health
What You Should Know: - Cerner Corporation today announced with Xealth new
centralized digital ordering and monitoring for health systems, starting with
Banner Health, to foster digital innovation. - Health systems can prescribe digital therapeutics, smartphones, and internet apps directly within the EHR to address areas such as chronic disease management, behavioral health, maternity care, and surgery prep. Cerner, today announced it’s building on the recent collaboration with
Read More
Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms
What You Should Know: - Lightspeed Venture Partners, the VC behind Nest and GrubHub, is leading a $10 million round for Freespira, an FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities. - In 28 days, Freespira can reduce or eliminate panic
attacks and PTSD symptoms from home with just a tablet, sensor, and custom app.
There’s no medicine with possible side effects and no need
Read More
Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics
What You Should Know: - Pear Therapeutics today announced that it has
successfully closed an $80 million Series D financing led by SoftBank Vision
Fund 2. - Pear is the
leader in prescription digital therapeutics and the first company to receive
FDA authorization for a prescription digital therapeutic (PDT) to treat
disease. - Pear currently has three FDA authorized therapies, reSET, reSET-O and Somryst, for substance use disorder, opioid use disorder, and chronic insomnia,
Read More
Brigham, Biofourmis Co-Develops Tech Solution to Enable Home Hospital Care
What You Should Know: - Brigham is working with Biofourmis on a national
rollout of their co-developed technology solution, which has been refined and
scaled for use by other healthcare systems across the country seeking to
establish and execute similar home hospital programs to alleviate COVID-related
capacity issues and to receive 1:1 parity on payments from CMS. - The Hospital@HomeTM platform provides a turnkey,
end-to-end ecosystem for any health system that wants to quickly launch
Read More
UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications
What You Should Know: - UCB has selected Medisafe to develop branded digital
drug companions for antiepileptic medications, marking the company’s official
entry into the digital therapeutics space. - The initial collaboration will primarily be focused on their antiepileptic medications, but they are exploring its use for additional brands. Medisafe,
a leading digital
therapeutics company specializing in digital companions, has been selected
by UCB to develop branded digital
Read More
